US-based Natus Medical has completed its acquisition of Canada-based Excel-Tech, by way of a statutory plan of arrangement in Canada.
Subscribe to our email newsletter
Under the terms of the arrangement, Natus has acquired all of the outstanding common shares of Excel-Tech (Xltek) at a cash price of C$3.25 per share. The transaction is valued at approximately $63.5 million.
Jim Hawkins, president and CEO of Natus, said: “We are very pleased to have acquired Xltek, as it affirms our position as a market leader in neurology and brings Natus one step closer to achieving our stated goal of growing revenue to a $250 million annual run-rate by the end of 2008.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.